Ionis Pharmaceuticals, Inc.
(NASDAQ : IONS)

( )
IONS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.11%62.180.0%$1999.69m
REGNRegeneron Pharmaceuticals, Inc. -2.18%599.472.5%$1212.04m
GILDGilead Sciences, Inc. -3.43%75.161.0%$972.03m
NVAXNovavax, Inc. 14.73%52.82102.0%$711.68m
AMGNAmgen, Inc. -1.22%226.911.3%$619.06m
VRTXVertex Pharmaceuticals, Inc. -0.46%286.641.9%$592.02m
BIIBBiogen, Inc. -1.84%301.451.6%$385.60m
ILMNIllumina, Inc. 0.65%365.413.5%$384.25m
SRNESorrento Therapeutics, Inc. -0.99%5.001.8%$320.03m
ALXNAlexion Pharmaceuticals, Inc. -0.82%118.922.0%$296.17m
SGENSeattle Genetics, Inc. 1.15%159.026.1%$258.80m
AAgilent Technologies, Inc. 2.01%89.911.6%$212.68m
BMRNBioMarin Pharmaceutical, Inc. 0.79%107.394.3%$185.56m
MGNXMacroGenics, Inc. 9.67%21.106.2%$174.18m
INCYIncyte Corp. -0.16%101.752.5%$166.58m

Company Profile

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.